• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    A Look At Marsh & McLennan Companies’s Valuation As Leadership Roles Expand At The Top Level

    Simply Wall St·04/14/2026 19:12:54
    Listen to the news

    Marsh & McLennan Companies (MRSH) is back in focus after Chief Financial Officer Mark McGivney was appointed Executive Vice President and Chief Operating Officer, expanding his role in firm wide execution and inorganic initiatives.

    See our latest analysis for Marsh & McLennan Companies.

    The latest management changes arrive after a period where the share price has been soft, with a 90 day share price return showing a decline of 5.01% and a 1 year total shareholder return showing a decline of 25.47%. This suggests momentum has been fading, despite longer term total shareholder returns over three and five years remaining positive.

    If this leadership reshuffle has you rethinking your portfolio, it can help to see what else is moving and uncover 18 top founder-led companies

    With revenue and net income both growing, an intrinsic discount of about 41% and the share price sitting around US$173.55 versus a US$202.85 target, is there a genuine opportunity here or is the market already pricing in future growth?

    Most Popular Narrative: 15.9% Undervalued

    At a last close of $173.55 against a narrative fair value of $206.40, the current price sits below what the most followed narrative is assuming, putting more attention on the earnings and margin story that underpins that gap.

    Strategic investments in digital transformation, advanced analytics, and AI (e.g., proprietary data tools for risk modeling, agentic interfaces) are expected to enhance operational efficiency and improve product/service offerings, enabling margin expansion and net earnings growth through improved client retention and lower cost to serve.

    Read the complete narrative.

    If you want to see what sits behind that earnings and margin push, the narrative lays out a detailed path for revenue, profitability, and valuation multiples without assuming runaway growth. Result: Fair Value of $206.40 (UNDERVALUED).

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, that gap to fair value could close quickly if softer property and reinsurance pricing persists, or if acquisition integration drags on margins and earnings.

    Find out about the key risks to this Marsh & McLennan Companies narrative.

    Another Way To Look At Valuation

    The narrative points to Marsh & McLennan as around 16% undervalued, but the P/E ratio of 20.2x tells a tighter story. It sits well above the US Insurance industry at 11.4x and above an estimated fair ratio of 13.1x, which leans more toward valuation risk than a clear bargain. Which signal do you trust more?

    See what the numbers say about this price — find out in our valuation breakdown.

    NYSE:MRSH P/E Ratio as at Apr 2026
    NYSE:MRSH P/E Ratio as at Apr 2026

    Next Steps

    With mixed signals on value and sentiment, assess whether the current setup matches your own thesis, take a closer look at the data and weigh 4 key rewards and 2 important warning signs

    Looking for more investment ideas?

    If Marsh & McLennan has sparked fresh thinking, do not stop here. Use the Simply Wall Street Screener to compare other opportunities before you commit new capital.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.